Publications Database

McDougle C. J. , Kem D. , Posey D. J. (2002)

Case series: use of ziprasidone for maladaptive symptoms in youths with autism.

Journal of the American Academy of Child and Adolescent Psychiatry

41(8), pp. 921-927

Read Abstract (New Window)

McDougle C. J. et al. (1992)

Clomipramine in autism: preliminary evidence of efficacy.

Journal of the American Academy of Child and Adolescent Psychiatry

31(4), pp. 746-750.

Read Abstract (New Window)

McDougle C. J. , Kresch L. E. , Posey D. J. (2000)

Repetitive thoughts and behavior in pervasive developmental disorders: treatment with serotonin reuptake inhibitors.

Journal of Autism and Developmental Disorders

30(5), pp. 427-435

Read Abstract (New Window)

McDougle C. J. et al. (2000)

Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidone.

Child and Adolescent Psychiatric Clinics of North America

January, 9(1), pp. 201-224.

Read Abstract (New Window)

McDougle C. J. et al. (2005)

Risperidone for the core symptom domains of autism: results from the study by the Autism Network of the Research Units on Pediatric Psychopharmacology.

American Journal of Psychiatry

162(6), pp. 1142-1148

Read Abstract (New Window) Read Full (New Window)

McDougle C. J. et al. (1997)

Risperidone treatment of children and adolescents with pervasive developmental disorders: A prospective, open-label study.

Journal of the American Academy of Child and Adolescent Psychiatry

36 pp. 685-693

Read Abstract (New Window)

McDougle C. J. , Stigler K. A. , Posey D. J. (2003)

Treatment of aggression in children and adolescents with autism and conduct disorder.

Journal of Clinical Psychiatry

64 pp. 16-25

Read Abstract (New Window)

Minshawi N. F. et al. (2016)

A randomized, placebo-controlled trial of d-cycloserine for the enhancement of social skills training in autism spectrum disorders.

Molecular Autism

7(2),

Read Full (New Window)

Minshawi N. F. et al. (2015)

Multidisciplinary assessment and treatment of self-injurious behavior in autism spectrum disorder and intellectual disability: Integration of psychological and biological theory and approach.

Journal of Autism and Developmental Disorders

45(6), pp. 1541-1568.

Read Abstract (New Window)

Minshawi N. F. et al. (2014)

The association between self-injurious behaviors and autism spectrum disorders.

Psychology research and behavior management

pp. 125-136.

Read Abstract (New Window) Read Full (New Window)

Nikolov R. N. et al. (2009)

Gastrointestinal symptoms in a sample of children with pervasive developmental disorders.

Journal of Autism and Developmental Disorders

39(3), pp. 405-413

Read Abstract (New Window)

Orsagh-Yentis D. K. et al. (2011)

Buspirone for bruxism in a child with pervasive developmental disorder-not otherwise specified

Journal of Child and Adolescent Psychopharmacology

Read Abstract (New Window)

Politte L. C. , McDougle C. J. (2014)

Atypical antipsychotics in the treatment of children and adolescents with pervasive developmental disorders.

Psychopharmacology (Berl)

March, 231(6), pp. 1023-1036.

Read Abstract (New Window)

Politte L. C. , Henry C. A. , McDougle C. J. (2014)

Psychopharmacological interventions in autism spectrum disorder.

Harvard Review of Psychiatry

22(2), pp. 76-92.

Read Abstract (New Window)

Posey D. J. et al. (2001)

A naturalistic open-label study of mirtazapine in autistic and other pervasive developmental disorders.

Journal of Child and Adolescent Psychopharmacology

11(3), pp. 267-277

Read Abstract (New Window)

Posey D. J. et al. (2004)

A pilot study of D-cycloserine in subjects with autistic disorder.

American Journal of Psychiatry

161(11), pp. :2115-2117

Read Abstract (New Window) Read Full (New Window)

Posey D. J. et al. (2008)

Antipsychotics in the treatment of autism.

Journal of Clinical Investigation

118(1), pp. 6-14

Read Abstract (New Window) Read Full (New Window)

Posey D. J. , Erickson C. A. , McDougle C. J. (2008)

Developing drugs for core social and communication impairment in autism.

Child and Adolescent Psychiatric Clinics of North America

17(4), pp. 787-801

Read Abstract (New Window) Read Full (New Window)

Posey D. J. , McDougle C. J. (2001)

Pharmacotherapeutic management of autism.

Expert Opinion on Pharmacotherapy

2(4), pp. 587-600

Read Abstract (New Window)

Posey D. J. et al. (2007)

Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures.

Biological Psychiatry

61(4), pp. 538-544.

Read Full (New Window)